FDA panel unanimously votes down Parkinson's drug
A panel of federal medical specialists has unanimously voted that a drug for Parkinson's disease from Teva Pharmaceuticals has not been shown to slow progress of the debilitating neurological disease.
Oct 17, 2011
0
0